Willing and able to provide written informed consent for this study and HIPAA authorization for the release of personal health information.
Age \>18
Participating in the SYNGERY-201 clinical trial.
You may not be if
History or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the study
History or current evidence of any condition, therapy, or laboratory abnormality that might interfere with the subject's participation for the full duration of the study
History or current evidence of any condition, therapy, or laboratory abnormality that is not in the best interest of the subject to participate (in the opinion of the treating investigator)
Clareo Health | COMPASS Study for Metastatic Castration-resistant Prostate Cancer
